Whitelab Genomics Analysis: $10M Raised
What is Whitelab Genomics?
Whitelab Genomics utilizes AI and biological data to enhance drug development in genomic medicine, focusing on the safety and efficacy of therapeutic candidates.
Employees
25
Founded
2019
Revenue
$7.4M
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
- Gene & RNA-based therapies, Target Receptors Identification, Viral Vector Design, Non-Viral Vector Design, Payload Design, Bioproduction Optimization, Cell Therapy Pipeline.
How much Whitelab Genomics raised
1 - $10 million
September 12, 2022Lead Investor: Omnes Capital, Debiopharm
Who are the founders of Whitelab Genomics
DD
David Delbourgo
Founder
JC
Julien Cottineau
Founder
Investors
- WhiteLab Genomics has raised $10 million in funding.
- The funding round was led by investors including:
